Catalyst Pharmaceuticals Inc (CPRX)
EBITDA Margin
62.92%
Quarterly · Period ending:
CPRX EBITDA Margin
Latest reported62.92%period ending
Latest reported62.92%period ending
CPRX Quarterly EBITDA Margin (0.00% → 62.92%)
Quarterly ebitda margin
High-resolution chart · PNG
CPRX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 62.9239% | |
| 53.3624% | |
| 54.2152% | |
| 53.7332% | |
| 57.0962% | |
| 58.9755% | |
| 51.7938% | |
| 53.1521% | |
| 39.102% | |
| 50.5119% | |
| -28.424% | |
| 57.3216% | |
| 51.4409% | |
| 55.3401% | |
| 46.3979% | |
| 53.2487% | |
| 40.5974% | |
| 33.5326% | |
| 39.2251% | |
| 43.8086% | |
| 32.7694% | |
| 27.8876% | |
| 40.0246% | |
| 37.0548% | |
| 36.9873% | |
| 27.4801% | |
| 46.1045% | |
| 39.5869% | |
| -7.8244% | |
| -2,966.1548% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -148.4269% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1,007.7169% | |
| 0% | |
| 0% | |
| 0% | |
| 953.3473% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |